Networks for Cancer Genomics Analysis
This page provides direct download to several interaction networks that may be useful in Cancer Genomics Analysis.
Networks are derived from Pathway Commons.
Binary or Pairwise Interaction Networks
Binary or pairwise interaction networks consist of gene nodes and edge interactions only, and do not represent the full semantic complexity of biological pathways.
They can, however, be useful for many different types of network analyses in cancer genomics.
- Binary or pairwise interaction network consisting of interactions derived from HPRD, NCI-Nature Pathway Interaction Database, Reactome, and the MSKCC Cancer Cell Map. The network was constructed as described in Cerami et al., but has since
been updated to reflect current data in Pathway Commons.
- Pathway Commons also provides pairwise interaction networks for individual data sources. They can be downloaded in the Simple Interaction Format (SIF), described in the Pathway Commons README:
BioPax is a standard language that aims to enable integration, exchange, visualization and analysis of biological pathway data.
Unlike the pairwise interactions above, BioPAX is able to represent the rich biological complexity of multiple types of biological pathways, including
metabolic pathways, molecular interactions, signaling pathways (including molecular states and generics), gene regulation and genetic interactions.
All data from the NCI-Nature Pathway Interaction Database, Reactome, and the MSKCC Cancer Cell Map can be downloaded in BioPAX format:
MSKCC Cell Map
Additional downloads in BioPAX format are available from Pathway Commons.
• New data and features released
Or follow us @cbioportal on Twitter
• New tools released
The Portal contains data for 20958 tumor samples from 89 cancer studies. [Details.]
RAS/RAF alterations in colorectal cancer
BRCA1 and BRCA2 mutations in ovarian cancer
POLE hotspot mutations in endometrial cancer
Protein changes in PTEN-altered ovarian cancer samples
TP53 and MDM2/4 alterations in GBM
PTEN mutations in GBM in text format
BRAF V600E mutations across cancer types
Patient view of an endometrial cancer case
What People are Saying
"Whenever bench scientists ask me how they can look at TCGA data, I've never
had a good answer for them. Now I do. The cBio Portal meets a critical need--it is the
interface that the cancer research community needs to access the wealth of TCGA. Even as a
computational biologist, I use it to follow-up on genes of interest. It makes querying
the data much less painful."
– Postdoctoral Fellow, Oregon Health & Science University
"I would like to congratulate you and the team of the cBio portal.
It's just an amazing tool to work with, and we at Mass General really appreciate it."
– Research Fellow at Massachusetts General Hospital
"As a bench biologist with primary aim of determining gene aberrations in GBM, I found
your site absolutely fantastic! Thank you! I have to reiterate how awesome and user-friendly
your group has made this site - finally accomplishing the goal of having data easily accessible
– Sr. Research Associate at Knight Cancer Institute/OHSU
"Thank you for your incredible resource that has helped greatly in accessing the TCGA
– Postdoctoral Fellow, Johns Hopkins University School of Medicine,
Dept Radiation Oncology and Molecular Radiation Sciences
"I have been enjoying the ease with which TCGA data can be extracted in R using your CGDS package.
Very nice work!"
– Sr. Software Engineer, Institute for Systems Biology
"Thank you for generating such an excellent software. It is very useful for our research."
– Research Fellow, Memorial Sloan-Kettering Cancer Center
"Thank you very much for providing and maintaining this great resource."
– Scientist, Discovery Bioinformatics, Biotechnology Company
"I want to thank you for the nice, useful and user-friendly interface you have generated
and shared with the community."
– Postdoctoral Fellow, Harvard Medical School, Children's Hospital Boston
"This portal is truly the greatest thing since sliced bread. I am making discoveries with it not only in glioblastoma, my primary focus, but in other cancers as well -- it's all so easy with this fantastic tool. And I am enjoying showing it to my colleagues, whose jaws also drop. Thank you a thousand times over for this beautiful public resource. I am looking forward to citing this soon in an upcoming paper..."
– Associate Professor, University of Virginia